CD3 staining in immunohistochemistry

It is an immunohistochemistry test performed on a tissue sample, commonly from a biopsy. A positive stain means the tested cells display CD3; it does not, by itself, establish whether the cells are reactive or cancerous.

The pathologist examines which cells stain, where they sit in the tissue, how strongly they stain, and whether their pattern looks expected. CD3 is usually found on T lymphocytes, so it can help distinguish a T-cell population from cells with other lineages.

Interpretation depends on the tissue architecture, cell appearance, clinical history, and a panel of additional markers. Loss, reduced expression, or an unusual distribution of CD3 may support further investigation, but no single staining pattern should be read in isolation.

Review the final pathology diagnosis rather than focusing only on the word positive or negative. Your clinician may compare CD3 with other immune-cell markers and with blood tests, imaging, or flow cytometry. Occasionally, the laboratory needs extra stains or more tissue before it can classify a lymphoid process confidently.

Bring the complete report to your appointment and ask whether the finding represents an expected immune response, an abnormal population, or an indeterminate pattern that needs follow-up.

The stain result itself is not an emergency signal. Contact the clinician who ordered the test if the result appears in your portal without an explanation, if the biopsy area becomes increasingly red, swollen, painful, or drains fluid, or if fever develops after the procedure. Seek urgent care for trouble breathing, fainting, uncontrolled bleeding, or rapidly worsening symptoms.

Ask which cells showed CD3, whether their location and appearance were expected, which companion markers were used, whether the sample was adequate, and how the full pathology interpretation affects the next step in your care.